Related Experiment Videos
Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes
1Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona 85013, USA. RLUKAS@MHA.CHW.EDU
Neurochemical Research
|October 1, 1996
Summary
Substance P and related tachykinins noncompetitively inhibit nicotinic acetylcholine receptors (nAChR) function. These interactions reveal complex cross-talk between nicotinic cholinergic and tachykinin signaling in the nervous system.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Nicotinic acetylcholine receptors (nAChR) are crucial neurotransmitter receptors in the nervous system.
- Substance P (SP) is known to affect nAChR function, suggesting potential cross-talk between signaling pathways.
Purpose of the Study:
- To investigate the interactions between tachykinins and human nAChR subtypes.
- To elucidate the mechanism and potency of tachykinin inhibition on nAChR function.
Main Methods:
- Utilized clonal cell lines expressing specific human nAChR subtypes (ganglionic α3β4 and muscle-type α1β1γδ).
- Measured nAChR function using 86Rb+ efflux assays following acute exposure to tachykinins.
- Assessed the effect of SP on [3H]acetylcholine binding to nAChR.
Main Results:
- SP acutely inhibits human ganglionic and muscle-type nAChR function noncompetitively.
- Neurokinin A and eledoisin also inhibit nAChR function, but with lower potency than SP.
- Neurokinin B did not inhibit nAChR function, and SP blockade was insurmountable by increasing agonist concentrations.
Conclusions:
- Tachykinins, particularly SP, act as noncompetitive inhibitors of human nAChR subtypes.
- The potency of inhibition varies among different tachykinins and nAChR subtypes.
- Tachykinin actions at nAChR contribute to the complex regulation of nervous system activity through cross-talk with cholinergic signals.